Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where H A Verbrugh is active.

Publication


Featured researches published by H A Verbrugh.


Journal of Medical Microbiology | 1981

Escherichia coli antibodies in opsonisation and protection against infection.

Willemien C. van Dijk; H A Verbrugh; Marijke E. van der Tol; Roel Peters; J. Verhoef

The opsonic and protective capacities of rabbit antisera against Escherichia coli O, K and core-glycolipid cell-wall antigens were compared with specific antibody titres as measured by agglutination and enzyme-linked immunosorbent assay. Anti-O antisera were opsonic and protective against two noncapsulate strains. Only anti-K antisera were opsonic and protective against a K-antigen-containing strain. In a mouse model anti-core-glycolipid antiserum was not protective against challenge even by a strain bearing only core glycolipid.


Antimicrobial Agents and Chemotherapy | 1982

Influence of subinhibitory concentrations of penicillin, cephalothin, and clindamycin on Staphylococcus aureus growth in human phagocytic cells.

G R Elliott; Phillip K. Peterson; H A Verbrugh; M R Freiberg; J R Hoidal; P G Quie

After an initial 2-h incubation with phagocytic cells, the growth of surviving intracellular Staphylococcus aureus was examined in the presence of subinhibitory concentrations of penicillin, cephalothin, and clindamycin. One-tenth of the minimal inhibitory concentrations of these antibiotics markedly reduced bacterial growth in normal polymorphonuclear leukocytes. In contrast, when human alveolar macrophages were studied, no inhibition of growth was seen. Subinhibitory concentrations of these antibiotics and polymorphonuclear leukocytes acted synergistically to reduce intracellular survival of S. aureus. This synergy did not appear to be dependent upon the microbicidal potential of the leukocyte respiratory burst, since no differences were found when polymorphonuclear leukocytes obtained from patients with chronic granulomatous disease were compared with those from normal donors. Images


European Journal of Clinical Microbiology & Infectious Diseases | 1982

Effect of influenza viras on phagocytic cells

Yvette Debets-Ossenkopp; Elaine L. Mills; W. C. van Dijk; H A Verbrugh; J. Verhoef

Many viral infections predispose to bacterial superinfection, and it has been suggested that the increased susceptibility to bacterial infections is at least in part due to the effect of virus on the phagocytic cell function. Since the mechanisms by which the viruses affect neutrophil function are not well understood, we studied the function of polymorphonuclear leukocytes (PMNs) after incubation with influenza virus. Phagocytosis was assayed by incubating influenza virus (strain type A-Texas-77 [H2N2]) treated leukocytes with3H-thymidine-labelled staphylococci. The oxidative metabolism of the PMNs was studied by measuring the chemiluminescence generated by virus-treated PMNs after incubation with zymosan. Chemotaxis was measured under agarose. After incubation with 107 EID50 units of influenza virus, PMNs ingested only 35 % of the bacteria, whereas control leukocytes ingested over 80 %. Influenza virus also reduced the mobility of the PMNs and markedly suppressed the generation of chemiluminiscence. UV-killed virus with intact neuraminidase produced similar effects but virus with heat-inactivated neuraminidase did not. Virus envelope-neuraminidase may be responsible for some of the effects of the virus on the PMNs.


The Journal of Infectious Diseases | 1981

Antibodies to Cell Wall Peptidoglycan of Staphylococcus aureus in Patients with Serious Staphylococcal Infections

H A Verbrugh; Roel Peters; Maja Rozenberg-Arska; Phillip K. Peterson; J. Verhoef


Journal of Immunology | 1982

Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.

H A Verbrugh; Phillip K. Peterson; B Y Nguyen; S P Sisson; Y Kim


Journal of Immunology | 1980

Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies.

H A Verbrugh; W C van Dijk; Roel Peters; M E van Erne; M R Daha; Phillip K. Peterson; J. Verhoef


Infection and Immunity | 1979

Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.

W C Van Dijk; H A Verbrugh; M. E. Van Der Tol; Roel Peters; J. Verhoef


Journal of Clinical Microbiology | 1984

Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids.

H A Verbrugh; William F. Keane; W.E. Conroy; Phillip K. Peterson


Infection and Immunity | 1982

Differences in phagocytosis and killing by alveolar macrophages from humans, rabbits, rats, and hamsters.

B. Y. T. Nguyen; Phillip K. Peterson; H A Verbrugh; Paul G. Quie; John R. Hoidal


Immunology | 1979

The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.

H A Verbrugh; W C Van Dijk; Roel Peters; M. E. Van Der Tol; J. Verhoef

Collaboration


Dive into the H A Verbrugh's collaboration.

Top Co-Authors

Avatar

Phillip K. Peterson

Hennepin County Medical Center

View shared research outputs
Top Co-Authors

Avatar

J. Verhoef

University of Minnesota

View shared research outputs
Top Co-Authors

Avatar

Roel Peters

University of Minnesota

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul G. Quie

University of Minnesota

View shared research outputs
Top Co-Authors

Avatar

W C Van Dijk

University of Minnesota

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

G R Elliott

University of Minnesota

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge